Emerging research suggests that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may also offer a protective effect against certain cancers. Scientists are actively investigating the underlying mechanisms.
Emerging research suggests that GLP-1 receptor agonists, commonly used for diabetes and weight loss, may also offer a protective effect against certain cancers. Scientists are actively investigating the underlying mechanisms.